Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 14;6(5):e1163.
doi: 10.1002/hsr2.1163. eCollection 2023 May.

Provider confidence in counseling preconception, pregnant, and postpartum patients regarding COVID-19 vaccination: A cross-sectional survey study

Molly R Siegel  1 , Kaitlyn E James  1 , Elana Jaffe  2 , Michelle M L'Heureux  3 , Anjali J Kaimal  1 , Ilona T Goldfarb  1
Affiliations

Provider confidence in counseling preconception, pregnant, and postpartum patients regarding COVID-19 vaccination: A cross-sectional survey study

Molly R Siegel et al. Health Sci Rep. .

Abstract

Background and aims: Healthcare provider counseling surrounding COVID-19 vaccine in pregnancy and lactation is essential to vaccination uptake in this population; however, provider knowledge and confidence are not well characterized. We aimed to assess knowledge and confidence in COVID-19 vaccine counseling among practitioners who provide care to pregnant persons and to describe factors associated with confidence in counseling.

Methods: A web-based anonymous survey was distributed via email to a cross-sectional convenience sample of Obstetrics and Gynecology, Primary Care, and Internal Medicine faculty at three hospitals in a single healthcare network in Massachusetts, United States. Individual demographics and institution-specific variables were included in the survey along with questions assessing both attitudes toward COVID-19 illness and confidence in counseling regarding the use of the vaccine in pregnancy.

Results: Almost all providers (151, 98.1%) reported that they received a COVID-19 vaccine, and most (111, 72.1%) reported that they believe the benefits of the vaccine in pregnancy outweigh the risks. Forty-one (26.6%) reported feeling very confident in counseling patients who primarily speak English about the evidence for messenger ribonucleic acid vaccination in pregnancy, and 36 (23%) reported feeling very confident in counseling patients who are not primarily English-speaking. Forty-three providers (28.1%) expressed strong confidence in their comfort talking to individuals with vaccine hesitancy based on historic and continued racism and systemic injustices. The sources that survey respondents most used to find information regarding COVID-19 vaccination in pregnancy were the Centers for Disease Control (112, 74.2%), hospital-specific resources (94, 62.3%), and the American College of Obstetricians and Gynecologists (82, 54.3%).

Conclusion: Ensuring that providers feel comfortable bridging the gap between their belief that the vaccine is beneficial for pregnant patients and their comfort with holding conversations with patients regarding vaccination is paramount to ensure equitable access to vaccines for pregnant patients.

Keywords: COVID‐19; postpartum; preconception; pregnancy; vaccine counseling; vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Attitudes toward mRNA COVID‐19 vaccine. mRNA, messenger RNA.
Figure 2
Figure 2
Counseling Confidence in primarily English‐speaking and primarily non‐English‐speaking patients. mRNA, messenger RNA.
Figure 3
Figure 3
Provider comfort with counseling patients with vaccine hesitancy.
See this image and copyright information in PMC

References

    1. Crane MA, Jaffe E, Beigi RH, et al. Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination. Am J Obstet Gynecol. 2021;225(5):95‐99. - PMC - PubMed
    1. Yap M, Debenham L, Kew T, et al. Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID‐19 in pregnancy and postpartum: a living systematic review protocol. BMJ Open. 2020;10(12):e041868. - PMC - PubMed
    1. Luxi N, Giovanazzi A, Capuano A, et al. COVID‐19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS‐CoV‐2 infection: overview of current recommendations and pre‐ and Post‐Marketing evidence for vaccine efficacy and safety. Drug Saf. 2021;44(12):1247‐1269. - PMC - PubMed
    1. The American College of Obstetricians and Gynecologists . Practice Advisory. Vaccinating pregnant and lactating patients against COVID‐19. Obstetrics and Gynecology. 2020. Accessed March 23, 2022. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl...
    1. The American College of Obstetricians and Gynecologists . ACOG Immunization ID, and Public Health Preparedness Expert Work Group. COVID‐19 vaccination considerations for obstetric‐gynecologic care. July 30, 2021.Accessed March 23, 2022. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articl...

LinkOut - more resources